|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/57 | |
| A61K 31/635 | |||
| A61P 9/02 | |||
| A61P 9/04 |
| (11) | Number of the document | 1863492 |
| (13) | Kind of document | T |
| (96) | European patent application number | 05814628.3 |
| Date of filing the European patent application | 2005-12-01 | |
| (97) | Date of publication of the European application | 2007-12-12 |
| (45) | Date of publication and mention of the grant of the patent | 2013-05-08 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2005/012843 |
| Date | 2005-12-01 |
| (87) | Number | WO 2006/058748 |
| Date | 2006-06-08 |
| (30) | Number | Date | Country code |
| 04028474 | 2004-12-01 | EP |
| (72) |
ANKER, Stefan, DE
|
| (73) |
Par Pharmaceuticals, Inc.,
One Ram Ridge Road, Spring Valley, NY 10977,
US
|
| (54) | USE OF MEGESTROL ACETATE FOR IMPROVING HEART FUNCTION AND THE TREATMENT OF HEART INSUFFICIENCY |
| USE OF MEGESTROL ACETATE FOR IMPROVING HEART FUNCTION AND THE TREATMENT OF HEART INSUFFICIENCY |